These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16400829)

  • 21. [Immunological aspects of multiple sclerosis].
    Miyagishi R; Fukaura H; Fukazawa T; Tashiro K
    No To Shinkei; 1993 Oct; 45(10):917-24. PubMed ID: 8268031
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J; Lublin FD
    Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
    Jalosinski M; Karolczak K; Mazurek A; Glabinski A
    Acta Neurol Scand; 2008 Aug; 118(2):120-5. PubMed ID: 18336625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nature, nurture, and microbes: The development of multiple sclerosis.
    Wekerle H
    Acta Neurol Scand; 2017 Nov; 136 Suppl 201():22-25. PubMed ID: 29068487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B; Archelos JJ; Hartung HP
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?
    Zweiman B; Lisak RP
    Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098
    [No Abstract]   [Full Text] [Related]  

  • 27. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translating new insights into treatment optimisation in multiple sclerosis.
    Fazekas F; Kieseier BC
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857
    [No Abstract]   [Full Text] [Related]  

  • 30. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
    Steinman L; Martin R; Bernard C; Conlon P; Oksenberg JR
    Annu Rev Neurosci; 2002; 25():491-505. PubMed ID: 12052918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.
    Aktas O; Kieseier B; Hartung HP
    Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune pathogenesis of multiple sclerosis.
    Wekerle H
    Neurol Sci; 2005 May; 26 Suppl 1():S1-2. PubMed ID: 15883678
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug Insight: using statins to treat neuroinflammatory disease.
    Weber MS; Prod'homme T; Steinman L; Zamvil SS
    Nat Clin Pract Neurol; 2005 Dec; 1(2):106-12. PubMed ID: 16932506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of chemokine signaling in patients with multiple sclerosis.
    Zipp F; Hartung HP; Hillert J; Schimrigk S; Trebst C; Stangel M; Infante-Duarte C; Jakobs P; Wolf C; Sandbrink R; Pohl C; Filippi M;
    Neurology; 2006 Nov; 67(10):1880-3. PubMed ID: 17130431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history of relapses in multiple sclerosis.
    Vollmer T
    J Neurol Sci; 2007 May; 256 Suppl 1():S5-13. PubMed ID: 17346747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perivascular spaces and the two steps to neuroinflammation.
    Owens T; Bechmann I; Engelhardt B
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1113-21. PubMed ID: 19018243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The brain--a special case of immune defense. New insights into the immunologic status of the central nervous system].
    Frese W
    Fortschr Med; 1985 Nov; 103(42):80-1. PubMed ID: 3878319
    [No Abstract]   [Full Text] [Related]  

  • 40. CSF analysis in suspected MS: do bands aid?
    Hintzen RQ; Giovannoni G
    Neurology; 2008 Mar; 70(13 Pt 2):1059-60. PubMed ID: 18362264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.